About: BL-1020     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:Tranquilizer104470232, within Data Space : dbpedia.org:8891 associated with source document(s)
QRcode icon
http://dbpedia.org:8891/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FBL-1020

BL-1020 (perphenazine 4-aminobutanoate) is an investigational orally-active antipsychotic for the possible treatment of schizophrenia. The chemical is an ester of GABA and perphenazine; pharmacologically it acts as a D2 antagonist and GABA agonist. It has shown pro-cognitive effects in the trials. In March 2013, it went into the II/III trial phase. It has been introduced by BioLineRx, a biopharmaceutical development company.

AttributesValues
rdf:type
rdfs:label
  • BL-1020 (en)
  • BL 1020 (fr)
rdfs:comment
  • BL-1020 (perphenazine 4-aminobutanoate) is an investigational orally-active antipsychotic for the possible treatment of schizophrenia. The chemical is an ester of GABA and perphenazine; pharmacologically it acts as a D2 antagonist and GABA agonist. It has shown pro-cognitive effects in the trials. In March 2013, it went into the II/III trial phase. It has been introduced by BioLineRx, a biopharmaceutical development company. (en)
  • Le BL-1020 (4-aminobutanoate de perphenazine) est un antipsychotique. Il s'agit d'un ester de la perphénazine et du GABA, présentant moins d'effet indésirables que cette dernière ainsi que des effets pro-cognitifs dans les essais. Il a été développé par , une société pharmaceutique israélienne. (fr)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Perphenazine_gamma-aminobutyrate.svg
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
sameAs
dbp:wikiPageUsesTemplate
thumbnail
c
CAS number
ChEMBL
ChemSpiderID
Cl
H
IUPAC name
n
O
PubChem
s
SMILES
  • C1CNCCOCCCCN (en)
StdInChI
StdInChIKey
  • BABFYCSPNDKXRI-UHFFFAOYSA-N (en)
UNII
  • K1WO7H97QZ (en)
width
has abstract
  • BL-1020 (perphenazine 4-aminobutanoate) is an investigational orally-active antipsychotic for the possible treatment of schizophrenia. The chemical is an ester of GABA and perphenazine; pharmacologically it acts as a D2 antagonist and GABA agonist. It has shown pro-cognitive effects in the trials. In March 2013, it went into the II/III trial phase. It has been introduced by BioLineRx, a biopharmaceutical development company. (en)
  • Le BL-1020 (4-aminobutanoate de perphenazine) est un antipsychotique. Il s'agit d'un ester de la perphénazine et du GABA, présentant moins d'effet indésirables que cette dernière ainsi que des effets pro-cognitifs dans les essais. Il a été développé par , une société pharmaceutique israélienne. (fr)
prov:wasDerivedFrom
page length (characters) of wiki page
CAS number
  • 751477-01-7
ChEMBL
  • 1187646
FDA UNII code
  • K1WO7H97QZ
PubChem
  • 11203271
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3332 as of Dec 5 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (62 GB total memory, 44 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software